Ascorbic acid against reperfusion injury in human renal transplantation

Transplant International

Volumn 16, Issue 8, 2003, Pages 578-583

  Norio, Karri ^a   Wikström, Mårten ^b   Salmela, Kaija ^a   Kyllönen, Lauri ^a   Lindgren, Leena ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Ascorbic acid; Delayed graft function; Kidney transplantation

Indexed keywords

ASCORBIC ACID; CREATININE; EURO COLLINS SOLUTION; REACTIVE OXYGEN METABOLITE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CADAVER DONOR; CAUSE OF DEATH; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG EFFICACY; DRUG MECHANISM; EXTRACELLULAR MATRIX; GRAFT REJECTION; GRAFT SURVIVAL; HEMODIALYSIS PATIENT; HUMAN; HUMAN TISSUE; KIDNEY FUNCTION; KIDNEY PERFUSION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 0141706613     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00147-003-0588-0     Document Type: Article

References (32)

1. Cecka JM, Terasaki PI (1995) The UNOS scientific renal transplant registry. United Network for Organ Sharing. Clin Transpl 1-18
2. 2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem J 255:357-360
3. Davenport A, Hopton M, Bolton C (1995) Measurement of malondialdehyde as a marker of oxygen free radical production during renal allograft transplantation and the effect on early graft function. Clin Transplant 9:171-175
4. Dawidson IJ, Ar'Rajab A (1992) Perioperative fluid and drug therapy during cadaver kidney transplantation. Clin Transpl 267-284
5. Dingchao H, Zhiduan Q, Liye H, Xiaodong F (1994) The protective effects of high-dose ascorbic acid on myocardium against reperfusion injury during and after cardiopulmonary bypass. Thorac Cardiovasc Surg 42:276-278
6. Doppelfeld IS, Parnham MJ (1992) Experimental conditions determine effects of ascorbic acid on reperfusion injury: comparison of tissue damage with hemodynamic parameters in rat isolated hearts. Methods Find Exp Clin Pharmacol 14:419-430
7. Feldman HI, Gayner R, Berlin JA, Roth DA, Silibovsky R, Kushner S, Brayman KL, Burns JE, Kobrin SM, Friedman AL, Grossman RA (1996) Delayed function reduces renal allograft survival independent of acute rejection. Nephrol Dial Transplant 11:1306-1313
8. Halloran PF, Aprile MA, Farewell V, Ludwin D, Smith EK, Tsai SY, Bear RA, Cole EH, Fenton SS, Cattran DC (1988) Early function as the principal correlate of graft survival. A multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine. Transplantation 46:223-228
9. Hower R, Minor T, Schneeberger H, Theodorakis J, Rembold S, Illner WD, Hofmann GO, Fraunberger P, Isselhard W, Land W (1996) Assessment of oxygen radicals during kidney transplantation-effect of radical scavenger. Transpl Int [Suppl] 9:479-482
10. Humar A, Johnson EM, Payne WD, Wrenshall L, Sutherland DE, Najarian JS, Gillingham KJ, Matas AJ (1997) Effect of initial slow graft function on renal allograft rejection and survival. Clin Transplant 11:623-627
11. Koo DD, Welsh KI, Roake JA, Morris PJ, Fuggle SV (1998) Ischemia/reperfusion injury in human kidney transplantation: an immunohistochemical analysis of changes after reperfusion. Am J Pathol 153:557-566
12. Kyllönen L, Salmela K (2000) Transplantation of both kidneys from 408 donors; comparison of results. Transpl Int [Suppl] 13:95-98
13. Kyllönen LE, Salmela KT, Eklund BH, Halme LE, Höckerstedt KA, Isoniemi HM, Mäkisalo HJ, Ahonen J (2000) Long-term results of 1047 cadaveric kidney transplantations with special emphasis on initial graft function and rejection. Transpl Int 13:122-128
14. Land W, Schneeberger H, Schleibner S, Illner WD, Abendroth D, Rutili G, Arfors KE, Messmer K (1994) The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation 57:211-217
15. Lee KC, Hamel DW, Kunbel S (1993) Rodent model of renal ischemia and reperfusion injury: influence of body temperature, seasonal variation, tumor necrosis factor, endogenous and exogenous antioxidants. Methods Find Exp Clin Pharmacol 15:153-159
16. Lodge JP, Kashi SH, Lam FT, Lord A, Giles GR (1993) The reflush effect-a prospective analysis of late perfusion. Transplantation 55:567-572
17. Lykkesfeldt J, Loft S, Poulsen HE (1995) Determination of ascorbic acid and dehydroascorbic acid in plasma by high-performance liquid chromatography with coulometric detection-are they reliable biomarkers of oxidative stress? Anal Biochem 229:329-335
18. Marcen R, Orofino L, Pascual J, de la Cal MA, Teruel JL, Villafruela JJ, Rivera ME, Mampaso F, Burgos FJ, Ortuno J (1998) Delayed graft function does not reduce the survival of renal transplant allografts. Transplantation 66:461-466
19. Massoudy P, Mempel T, Raschke P, Becker BF (1999) Reduction of oxygen delivery during post-ischemic reperfusion protects the isolated guinea pig heart. Basic Res Cardiol 94:231-237
20. Masters TN, Fokin AA, Schaper J, Lorenz-Meyer S, Pool L, Gong G, Robicsek F (2000) Extending myocardial viability during heart preservation with cyclosporine A. J Card Surg 15:392-402
21. Nakagawa K, Koo DD, Davies DR, Gray DW, McLaren AJ, Welsh KI, Morris PJ, Fuggle SV (2002) Lecithinized superoxide dismutase reduces cold ischemia-induced chronic allograft dysfunction. Kidney Int 61:1160-1169
22. Niki E (1991) Action of ascorbic acid as a scavenger of active and stable oxygen radicals. Am J Clin Nutr [Suppl] 54:1119-1124
23. Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL (1997) Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 63:968-974
24. Perez Fontan M, Rodriguez-Carmona A, Bouza P, Valdes F (1998) The prognostic significance of acute renal failure after renal transplantation in patients treated with cyclosporin. QJM 91:27-40
25. Pfaff WW, Howard RJ, Patton PR, Adams VR, Rosen CB, Reed AI (1998) Delayed graft function after renal transplantation. Transplantation 65:219-223
26. Ponka A, Kuhlback B (1983) Serum ascorbic acid in patients undergoing chronic hemodialysis. Acta Med Scand 213:305-307
27. Roake JA, Fawcett J, Koo DD, Fuggle SV, Gray DW, Morris PJ (1996) Late reflush in clinical renal transplantation. Protection against delayed graft function not observed. Transplantation 62:114-116
28. Rosenthal JT, Danovitch GM, Wilkinson A, Ettenger RB (1991) The high cost of delayed graft function in cadaveric renal transplantation. Transplantation 51:1115-1118
29. Shah GM, Ross EA, Sabo A, Pichon M, Bhagavan H, Reynolds RD (1991) Ascorbic acid supplements in patients receiving chronic peritoneal dialysis. Am J Kidney Dis 18:84-90
30. Togashi H, Shinzawa H, Yong H, Takahashi T, Noda H, Oikawa K, Kamada H (1994) Ascorbic acid radical, superoxide, and hydroxyl radical are detected in reperfusion injury of rat liver using electron spin resonance spectroscopy. Arch Biochem Biophys 308:1-7
31. Troppmann C, Gillingham KJ, Gruessner RW, Dunn DL, Payne WD, Najarian JS, Matas AJ (1996) Delayed graft function in the absence of rejection has no long-term impact. A study of cadaver kidney recipients with good graft function at 1 year after transplantation. Transplantation 61:1331-1337
32. Tsapas G, Magoula I, Paletas K, Concouris L (1983) Effect of peritoneal dialysis on plasma levels of ascorbic acid. Nephron 33:34-37